Carnegie Mellon University’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31K Buy
4,482
+10
+0.2% +$3 ﹤0.01% 4
2025
Q4
$1.35K Sell
4,472
-10
-0.2% -$3 ﹤0.01% 5
2025
Q3
$3.18K Hold
4,482
﹤0.01% 5
2025
Q2
$11.3K Hold
4,482
0.01% 4
2025
Q1
$16.8K Hold
4,482
0.01% 5
2024
Q4
$37.5K Hold
4,482
0.03% 4
2024
Q3
$54K Buy
4,482
+1,047
+30% +$28.6K 0.06% 2
2024
Q2
$137K Hold
3,435
0.19% 2
2024
Q1
$264K Hold
3,435
0.33% 3
2023
Q4
$393K Hold
3,435
0.47% 2
2023
Q3
$371K Buy
+3,435
New +$518K 0.47% 3

Other funds holding XAGE

Carnegie Mellon University's XAGE Position: Q1 2026 in Review

Carnegie Mellon University increased its Longevity Health Holdings, Inc. Common Stock (XAGE) stake by 0.22% in Q1 2026, buying an estimated $3 and bringing the position to 4,482 shares worth $1.31K. The position accounts for ﹤0.01% of the portfolio, ranked #4.

Carnegie Mellon University first reported a position in XAGE in Q3 2023 and has held it in 11 quarters since. The position peaked at $393K in Q4 2023. 2 funds tracked by Wall St. Rank hold XAGE as of Q1 2026.

  • Carnegie Mellon University held 4,482 shares of Longevity Health Holdings, Inc. Common Stock worth $1.31K as of Q1 2026.
  • Carnegie Mellon University bought 10 Longevity Health Holdings, Inc. Common Stock shares in Q1 2026, an estimated $3.
  • Longevity Health Holdings, Inc. Common Stock made up ﹤0.01% of Carnegie Mellon University's portfolio in Q1 2026, its #4 holding.
  • Carnegie Mellon University first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2023 and has held it in 11 quarters since.
  • Carnegie Mellon University's Longevity Health Holdings, Inc. Common Stock position peaked at $393K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q1 2026.

Based on Carnegie Mellon University's 13F filing for Q1 2026, filed 13 May 2026.